These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 26238486)
1. mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells. Huijts CM; Schneiders FL; Garcia-Vallejo JJ; Verheul HM; de Gruijl TD; van der Vliet HJ J Immunol; 2015 Sep; 195(5):2038-45. PubMed ID: 26238486 [TBL] [Abstract][Full Text] [Related]
2. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. Moreira-Teixeira L; Resende M; Devergne O; Herbeuval JP; Hermine O; Schneider E; Dy M; Cordeiro-da-Silva A; Leite-de-Moraes MC J Immunol; 2012 Jan; 188(2):624-31. PubMed ID: 22156591 [TBL] [Abstract][Full Text] [Related]
3. Comment on "mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells". Moreira-Teixeira L; Leite-de-Moraes M J Immunol; 2015 Dec; 195(11):5100-1. PubMed ID: 26589745 [No Abstract] [Full Text] [Related]
4. Response to Comment on "mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells". Huijts CM; de Gruijl TD; van der Vliet HJ J Immunol; 2015 Dec; 195(11):5101-2. PubMed ID: 26589746 [No Abstract] [Full Text] [Related]
5. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells. Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038 [TBL] [Abstract][Full Text] [Related]
6. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells. Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881 [TBL] [Abstract][Full Text] [Related]
7. Oscillatory mTOR inhibition and Treg increase in kidney transplantation. Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of canonical NF-κB signaling maintains function and stability of human Treg. Ziegler LS; Gerner MC; Schmidt RLJ; Trapin D; Steinberger P; Pickl WF; Sillaber C; Egger G; Schwarzinger I; Schmetterer KG FEBS J; 2021 Jan; 288(2):640-662. PubMed ID: 32386462 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions. Boor PP; Metselaar HJ; Mancham S; van der Laan LJ; Kwekkeboom J Clin Exp Immunol; 2013 Dec; 174(3):389-401. PubMed ID: 23968562 [TBL] [Abstract][Full Text] [Related]
10. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4. Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658 [TBL] [Abstract][Full Text] [Related]
11. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model. Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710 [TBL] [Abstract][Full Text] [Related]
12. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204 [TBL] [Abstract][Full Text] [Related]
13. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. Monteiro M; Almeida CF; Caridade M; Ribot JC; Duarte J; Agua-Doce A; Wollenberg I; Silva-Santos B; Graca L J Immunol; 2010 Aug; 185(4):2157-63. PubMed ID: 20639482 [TBL] [Abstract][Full Text] [Related]
14. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions. Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457 [TBL] [Abstract][Full Text] [Related]
15. Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity. Li Q; Shakya A; Guo X; Zhang H; Tantin D; Jensen PE; Chen X J Immunol; 2012 May; 188(9):4268-77. PubMed ID: 22490438 [TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger. Prevot N; Pyaram K; Bischoff E; Sen JM; Powell JD; Chang CH J Immunol; 2015 Jan; 194(1):223-30. PubMed ID: 25404366 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Ahn JS; Krishnadas DK; Agrawal B Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657 [TBL] [Abstract][Full Text] [Related]
18. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells. Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431 [TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]